
|Articles|April 3, 2006
Latebreakers: April 3, 2006
President Bush nominated acting FDA commissioner Andrew vonEschenbach, M.D., to permanently head the agency. Eschenbach, whoalso heads the National Cancer Institute, may faceconflict-of-interest charges at his confirmation hearings, andSenate Democrats have threatened to hold up his confirmation overFDA's inaction on OTC status for the emergency contraceptive PlanB. NCPA and NACDS had no comment on the Eschenbach nomination, butAPhA views him as an "excellent choice."
Advertisement
Newsletter
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
Orforglipron Maintains Weight Loss After Discontinuation of Injectable GLP-1
2
Rethinking Acute Pain Management in the Age of Prescription Topicals
3
FDA Approves Tradipitant for Prevention of Vomiting From Motion Sickness
4
Insulin Management: Most-Read Stories of 2025
5














































































































